{"id":"W2000781940","doi":"10.1158/1538-7445.am2014-ct230","title":"Abstract CT230: Pediatric phase 1 trial of moxetumomab pasudotox: Activity in chemotherapy refractory acute lymphoblastic leukemia (ALL)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Adverse effect; Refractory (planetary science); Dexamethasone; Chemotherapy; Cumulative incidence; Cytokine release syndrome; Surgery; Cohort; Cancer; Immunotherapy; Chimeric antigen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009028083,0.001349797,0.001117782,0.000322541,0.000332873,0.00092825,0.0007317578,0.0006572984,0.004844444],"category_scores_gemma":[0.000474002,0.0003012642,0.0006120892,0.000491196,0.0005986579,0.0004392936,0.0002957622,0.002699177,0.0007650684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001120136,"about_ca_system_score_gemma":0.001690542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002240394,"about_ca_topic_score_gemma":0.003643578,"domain_scores_codex":[0.9997882,0.0001137137,0.000008918443,0.00002954562,0.0000230082,0.00003660441],"domain_scores_gemma":[0.9996516,0.00004698292,0.00006735732,0.00002236675,0.00002106863,0.0001907087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6220092,0.03944538,0.01358677,0.002360322,0.001753649,0.001131808,0.0004540792,0.007427702,0.08993576,0.001008166,0.01932299,0.2015642],"study_design_scores_gemma":[0.5080245,0.4361269,0.02283272,0.0001572689,0.0007738285,0.001560301,0.00009509393,0.002194415,0.01645464,0.0003590177,0.01138091,0.00004037481],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901077,0.003554161,0.0003730428,0.0004842831,0.00006928544,0.001254719,0.001930576,0.0001304545,0.002095907],"genre_scores_gemma":[0.9827791,0.00421038,0.001490514,0.0006706493,0.000140728,0.002210303,0.004506915,0.00004802654,0.003943315],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004844444,"threshold_uncertainty_score":0.01620632,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05100296528398559,"score_gpt":0.4072639929385653,"score_spread":0.3562610276545797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}